Back
0001104659-22-060934
Avoro Capital Advisors LLC
Total Value: $5,477,562,000
Total Holdings: 43
QuarterFilling ID
Q4 250002002654-26-000001
Q3 250002002654-25-000006
Q2 250002002654-25-000004
Q1 250002002654-25-000003
Q4 240002002654-25-000001
Q3 240002002654-24-000005
Q2 240002002654-24-000004
Q1 240002002654-24-000002
Q4 230002002654-24-000001
Q3 230002002654-23-000008
Q2 230002002654-23-000007
Q1 230002002654-23-000006
Q4 220002002654-23-000005
Q3 220002002654-23-000004
Q2 220002002654-23-000003
Q1 220002002654-23-000002
Q4 210002002654-23-000001
Compare Quarter:
NameTitleCUSIPTickerValueSharesShare PriceInvestment% of Portfolio
HORIZON THERAPEUTICS PLCCommonG46188101$683,8656,500,000SOLE
UNITED THERAPEUTICS CORPCommon91307C102$543,6123,030,000SOLE
APELLIS PHARMACEUTICALS INCCommon03753U106$480,1559,450,000SOLE
MIRATI THERAPEUTICS INCCommon60468T105$437,8225,325,000SOLE
ARGENX SESponsored ADR04016X101$395,7141,255,000SOLE
SPDR SERIES TRUST – S&P BIOTECHETF78464A870$274,1343,050,000SOLE
ASCENDIS PHARMASponsored ADR04351P101$258,1922,200,000SOLE
SAREPTA THERAPEUTICS INCCommon803607100$244,9063,135,000SOLE
BIOMARIN PHARMACEUTICAL INCCommon09061G101$233,9993,035,000SOLE
ALNYLAM PHARMACEUTICALS INCCommon02043Q107$212,2771,300,000SOLE
AMICUS THERAPEUTICS INCCommon03152W109$194,13520,500,000SOLE
SEAGEN INCCommon81181C104$189,4261,315,000SOLE
XENON PHARMACEUTICALS INCCommon98420N105$152,3914,985,000SOLE
IOVANCE BIOTHERAPEUTICS INCCommon462260100$151,9319,125,000SOLE
MADRIGAL PHARMACEUTICALS INCCommon558868105$139,8211,425,000SOLE
IVERIC BIO INCCommon46583P102$122,0187,250,000SOLE
KURA ONCOLOGY INCCommon50127T109$77,1844,800,000SOLE
KRYSTAL BIOTECH INCCommon501147102$66,8731,005,000SOLE
ACADIA PHARMACEUTICALS INCCommon4225108$55,1012,275,000SOLE
MONTE ROSA THERAPEUTICS INCCommon61225M102$46,4263,311,434SOLE
PMV PHARMACEUTICALS INCCommon69353Y103$45,8042,200,000SOLE
SYNDAX PHARMACEUTICALS INCCommon87164F105$38,5922,220,500SOLE
DESIGN THERAPEUTICS INCCommon25056L103$35,8892,222,222SOLE
KYMERA THERAPEUTICS INCCommon501575104$34,554816,500SOLE
MANNKIND CORPCommon56400P706$32,3848,800,000SOLE
CYMABAY THERAPEUTICS INCCommon23257D103$32,03310,300,000SOLE
AADI BIOSCIENCES INCCommon00032Q104$31,0451,829,402SOLE
BIOCRYST PHARMACEUTICLAS INCCommon09058V103$30,4881,875,000SOLE
MARINUS PHARMACEUTICALS INCCommon56854Q200$29,4533,150,000SOLE
MERSANA THERAPEUTICS INCCommon59045L106$27,1326,800,000SOLE
AVIDITY BIOSCIENCES INCCommon05370A108$24,0111,300,000SOLE
PRAXIS PRECISION MEDICINES INCCommon74006W108$21,9522,150,000SOLE
DICE THERAPEUTICS INCCommon23345J104$20,5651,075,000SOLE
AMARIN CORP PLCSponsored ADR23111206$19,7406,000,000SOLE
ULTRAGENYX PHARMACEUTICAL INCCommon90400D108$16,703230,000SOLE
NUVALENT INCCommon670703107$14,5771,049,471SOLE
TANGO THERAPEUTICS INCCommon87583X109$11,7491,550,000SOLE
AVADEL PHARMACEUTICALS PLCSponsored ADR05337M104$11,4061,670,000SOLE
IO BIOTECH INCCommon449778109$9,5802,055,883SOLE
ADVERUM BIOTECHNOLOGIES INCCommon00773U108$9,1056,950,000SOLE
APPLIED MOLECULAR TRANS INCCommon03824M109$7,7461,030,000SOLE
FENNEC PHARMACEUTICALS INCCommon31447P100$6,7201,200,000SOLE
GENOCEA BIOSCIENCES INCCommon372427401$6,3555,084,184SOLE
© 2026 13F • Hedge Fund Alpha